CN109836397A - A kind of preparation method of biological buffer-morpholinopropane sulfonic acid (MOPS) - Google Patents
A kind of preparation method of biological buffer-morpholinopropane sulfonic acid (MOPS) Download PDFInfo
- Publication number
- CN109836397A CN109836397A CN201711206086.3A CN201711206086A CN109836397A CN 109836397 A CN109836397 A CN 109836397A CN 201711206086 A CN201711206086 A CN 201711206086A CN 109836397 A CN109836397 A CN 109836397A
- Authority
- CN
- China
- Prior art keywords
- preparation
- sulfonic acid
- reaction
- mops
- solvent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- DVLFYONBTKHTER-UHFFFAOYSA-N 3-(N-morpholino)propanesulfonic acid Chemical compound OS(=O)(=O)CCCN1CCOCC1 DVLFYONBTKHTER-UHFFFAOYSA-N 0.000 title claims abstract description 19
- 238000002360 preparation method Methods 0.000 title claims abstract description 19
- 239000007993 MOPS buffer Substances 0.000 title claims abstract 4
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 claims abstract description 24
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 20
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims abstract description 10
- 239000002904 solvent Substances 0.000 claims abstract description 10
- 239000003638 chemical reducing agent Substances 0.000 claims abstract description 6
- 229910052757 nitrogen Inorganic materials 0.000 claims abstract description 5
- FSSPGSAQUIYDCN-UHFFFAOYSA-N 1,3-Propane sultone Chemical compound O=S1(=O)CCCO1 FSSPGSAQUIYDCN-UHFFFAOYSA-N 0.000 claims abstract description 4
- 239000000047 product Substances 0.000 claims description 13
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 10
- 238000006243 chemical reaction Methods 0.000 claims description 10
- 239000003795 chemical substances by application Substances 0.000 claims description 8
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 claims description 6
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 6
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 6
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 6
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 6
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 6
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims description 6
- 239000012043 crude product Substances 0.000 claims description 6
- 239000002798 polar solvent Substances 0.000 claims description 6
- 238000003756 stirring Methods 0.000 claims description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 6
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 5
- 238000005406 washing Methods 0.000 claims description 5
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 claims description 4
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 4
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 4
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 claims description 4
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 4
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 claims description 4
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims description 4
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 4
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 claims description 4
- 238000001816 cooling Methods 0.000 claims description 4
- 239000008367 deionised water Substances 0.000 claims description 4
- 229910021641 deionized water Inorganic materials 0.000 claims description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 4
- 239000011261 inert gas Substances 0.000 claims description 4
- TZIHFWKZFHZASV-UHFFFAOYSA-N methyl formate Chemical compound COC=O TZIHFWKZFHZASV-UHFFFAOYSA-N 0.000 claims description 4
- 238000005119 centrifugation Methods 0.000 claims description 3
- 239000000706 filtrate Substances 0.000 claims description 3
- 238000001914 filtration Methods 0.000 claims description 3
- 238000000926 separation method Methods 0.000 claims description 3
- SCYULBFZEHDVBN-UHFFFAOYSA-N 1,1-Dichloroethane Chemical class CC(Cl)Cl SCYULBFZEHDVBN-UHFFFAOYSA-N 0.000 claims description 2
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 claims description 2
- DURPTKYDGMDSBL-UHFFFAOYSA-N 1-butoxybutane Chemical compound CCCCOCCCC DURPTKYDGMDSBL-UHFFFAOYSA-N 0.000 claims description 2
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical group CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 claims description 2
- KWYHDKDOAIKMQN-UHFFFAOYSA-N N,N,N',N'-tetramethylethylenediamine Chemical compound CN(C)CCN(C)C KWYHDKDOAIKMQN-UHFFFAOYSA-N 0.000 claims description 2
- 229910052786 argon Inorganic materials 0.000 claims description 2
- IEJIGPNLZYLLBP-UHFFFAOYSA-N dimethyl carbonate Chemical compound COC(=O)OC IEJIGPNLZYLLBP-UHFFFAOYSA-N 0.000 claims description 2
- 238000001035 drying Methods 0.000 claims description 2
- GNOIPBMMFNIUFM-UHFFFAOYSA-N hexamethylphosphoric triamide Chemical compound CN(C)P(=O)(N(C)C)N(C)C GNOIPBMMFNIUFM-UHFFFAOYSA-N 0.000 claims description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 2
- IMFACGCPASFAPR-UHFFFAOYSA-N tributylamine Chemical compound CCCCN(CCCC)CCCC IMFACGCPASFAPR-UHFFFAOYSA-N 0.000 claims description 2
- 229910052799 carbon Inorganic materials 0.000 claims 2
- USIUVYZYUHIAEV-UHFFFAOYSA-N diphenyl ether Chemical compound C=1C=CC=CC=1OC1=CC=CC=C1 USIUVYZYUHIAEV-UHFFFAOYSA-N 0.000 claims 2
- 235000019441 ethanol Nutrition 0.000 claims 2
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims 1
- BZHJMEDXRYGGRV-UHFFFAOYSA-N Vinyl chloride Chemical class ClC=C BZHJMEDXRYGGRV-UHFFFAOYSA-N 0.000 claims 1
- 150000001336 alkenes Chemical class 0.000 claims 1
- 238000004090 dissolution Methods 0.000 claims 1
- 150000002148 esters Chemical class 0.000 claims 1
- 125000005909 ethyl alcohol group Chemical group 0.000 claims 1
- 239000007789 gas Substances 0.000 claims 1
- XTAZYLNFDRKIHJ-UHFFFAOYSA-N n,n-dioctyloctan-1-amine Chemical compound CCCCCCCCN(CCCCCCCC)CCCCCCCC XTAZYLNFDRKIHJ-UHFFFAOYSA-N 0.000 claims 1
- KCXFHTAICRTXLI-UHFFFAOYSA-N propane-1-sulfonic acid Chemical compound CCCS(O)(=O)=O KCXFHTAICRTXLI-UHFFFAOYSA-N 0.000 claims 1
- 230000000630 rising effect Effects 0.000 claims 1
- JVBXVOWTABLYPX-UHFFFAOYSA-L sodium dithionite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])=O JVBXVOWTABLYPX-UHFFFAOYSA-L 0.000 claims 1
- 239000000126 substance Substances 0.000 claims 1
- 238000010792 warming Methods 0.000 claims 1
- 238000000034 method Methods 0.000 abstract description 17
- 239000002994 raw material Substances 0.000 abstract description 4
- VEFLKXRACNJHOV-UHFFFAOYSA-N 1,3-dibromopropane Chemical compound BrCCCBr VEFLKXRACNJHOV-UHFFFAOYSA-N 0.000 abstract description 3
- 230000009286 beneficial effect Effects 0.000 abstract description 3
- 238000004042 decolorization Methods 0.000 abstract description 3
- 238000003786 synthesis reaction Methods 0.000 abstract description 3
- 238000011031 large-scale manufacturing process Methods 0.000 abstract description 2
- 230000002194 synthesizing effect Effects 0.000 abstract description 2
- 238000002835 absorbance Methods 0.000 description 7
- 238000002425 crystallisation Methods 0.000 description 5
- 230000008025 crystallization Effects 0.000 description 5
- 239000007864 aqueous solution Substances 0.000 description 4
- 230000000052 comparative effect Effects 0.000 description 3
- GRWZHXKQBITJKP-UHFFFAOYSA-L dithionite(2-) Chemical group [O-]S(=O)S([O-])=O GRWZHXKQBITJKP-UHFFFAOYSA-L 0.000 description 3
- ATHHXGZTWNVVOU-UHFFFAOYSA-N N-methylformamide Chemical compound CNC=O ATHHXGZTWNVVOU-UHFFFAOYSA-N 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- 239000006177 biological buffer Substances 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 238000005070 sampling Methods 0.000 description 2
- 238000001308 synthesis method Methods 0.000 description 2
- 238000004448 titration Methods 0.000 description 2
- XFJQZJBQLJFFRR-UHFFFAOYSA-N 2,3,4-trichloro-5,6-dihydrobenzo[b][1]benzoxepine Chemical compound ClC=1C(=C(C2=C(C1)OC1=C(C=CC=C1)CC2)Cl)Cl XFJQZJBQLJFFRR-UHFFFAOYSA-N 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 239000000032 diagnostic agent Substances 0.000 description 1
- 229940039227 diagnostic agent Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 208000002672 hepatitis B Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 239000012452 mother liquor Substances 0.000 description 1
- IOQPZZOEVPZRBK-UHFFFAOYSA-N octan-1-amine Chemical compound CCCCCCCCN IOQPZZOEVPZRBK-UHFFFAOYSA-N 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
Landscapes
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Abstract
本发明属于有机合成领域,具体涉及一种生物缓冲剂—吗啉基丙烷磺酸(MOPS)的制备方法,包括以下步骤:吗啉与1,3‑丙烷磺酸内酯(1,3‑PS)反应生成吗啉基丙烷磺酸。本发明方法中所用的原料相对于使用1,3‑二溴丙烷与吗啉合成吗啉基丙烷磺酸的方法中所用的原料更便宜,有利于大规模生产应用。本发明采用乙醇等为溶剂,溶剂易除去,满足了用户对溶剂残留的要求。本发明方法中的脱色采用加还原剂并氮气保护的方法,确保了MOPS的色度,使得到的产物性状更好。本发明的制备工艺简单,操作方便,具有较高的实用性。The invention belongs to the field of organic synthesis, and in particular relates to a preparation method of a biological buffer-morpholinyl propane sulfonic acid (MOPS), comprising the following steps: morpholine and 1,3-propane sultone (1,3-PS) ) reacted to generate morpholino propane sulfonic acid. The raw material used in the method of the present invention is cheaper than the raw material used in the method for synthesizing morpholinopropane sulfonic acid using 1,3-dibromopropane and morpholine, and is beneficial to large-scale production and application. In the present invention, ethanol and the like are used as the solvent, the solvent is easy to remove, and the user's requirement for solvent residue is satisfied. The decolorization in the method of the invention adopts the method of adding a reducing agent and nitrogen protection, which ensures the chromaticity of the MOPS and makes the obtained product with better properties. The preparation process of the invention is simple, the operation is convenient, and the practicability is high.
Description
技术领域technical field
本发明属于有机合成领域,具体涉及一种生物缓冲剂—吗啉基丙烷磺酸 (MOPS)的制备方法。The invention belongs to the field of organic synthesis, and in particular relates to a preparation method of a biological buffer-morpholino propane sulfonic acid (MOPS).
背景技术Background technique
MOPS是一种用途很广的生物缓冲剂,它广泛用于细胞培养、生物发酵及生物制剂等方面,如用作乙肝诊断剂。MOPS is a very versatile biological buffer, which is widely used in cell culture, biological fermentation and biological preparations, such as hepatitis B diagnostic agent.
关于MOPS的合成方法报道很少,Anal.Chen.37(1).156-8 1965(Eng)最早报道了MOPS的合成方法;WO2001085678报道了以1,3-二溴丙烷与吗啉合成MOPS 的方法,但溴化物太贵,制备成本较高。There are few reports on the synthesis method of MOPS. Anal.Chen.37(1).156-8 1965 (Eng) first reported the synthesis method of MOPS; WO2001085678 reported the synthesis of MOPS with 1,3-dibromopropane and morpholine. method, but the bromide is too expensive and the preparation cost is higher.
因此,有必要对生物缓冲剂—吗啉基丙烷磺酸(MOPS)的制备方法进行改进。Therefore, it is necessary to improve the preparation method of biological buffer-morpholinyl propane sulfonic acid (MOPS).
发明内容SUMMARY OF THE INVENTION
为了改善上述问题,本发明提供了一种生物缓冲剂—吗啉基丙烷磺酸 (MOPS)的制备方法,包括以下步骤:吗啉与1,3-丙烷磺酸内酯(1,3-PS)反应生成吗啉基丙烷磺酸,In order to improve the above problems, the present invention provides a preparation method of a biological buffer, morpholino propane sulfonic acid (MOPS), comprising the following steps: morpholine and 1,3-propane sultone (1,3-PS) ) reacts to generate morpholino propane sulfonic acid,
所述反应可以在极性溶剂中进行;所述极性溶剂可以为甲醇、乙醇、异丙醇、正丁醇、甲酰胺、三氟乙酸、二甲基亚砜、乙腈、N,N-二甲基甲酰胺、六甲基磷酰胺、乙酸、吡啶、四甲基乙二胺、丙酮、三乙胺、二氧六环、四氢呋喃、甲酸甲酯、三丁胺、甲乙酮、乙酸乙酯、三辛胺、碳酸二甲酯、乙醚、异丙醚、正丁醚、三氯乙烯、二苯醚、二氯甲烷、氯仿、二氯乙烷、甲苯等中的一种或多种,所述溶剂优选为乙醇;The reaction can be carried out in a polar solvent; the polar solvent can be methanol, ethanol, isopropanol, n-butanol, formamide, trifluoroacetic acid, dimethyl sulfoxide, acetonitrile, N,N-diol. Methylformamide, hexamethylphosphoramide, acetic acid, pyridine, tetramethylethylenediamine, acetone, triethylamine, dioxane, tetrahydrofuran, methyl formate, tributylamine, methyl ethyl ketone, ethyl acetate, tris One or more of octylamine, dimethyl carbonate, diethyl ether, isopropyl ether, n-butyl ether, trichloroethylene, diphenyl ether, dichloromethane, chloroform, dichloroethane, toluene, etc., the solvent preferably ethanol;
根据本发明,所述溶剂在使用前,可以用脱色剂进行预处理至在260nm和 280nm处的紫外吸光度均小于0.05,所述脱色剂可以为活性炭;According to the present invention, before use, the solvent can be pretreated with a decolorizing agent until the UV absorbance at 260 nm and 280 nm are both less than 0.05, and the decolorizing agent can be activated carbon;
根据本发明,所述吗啉与1,3-丙烷磺酸内酯的摩尔比可以为(1.0~2.0):1,例如(1.02~1.2):1;According to the present invention, the molar ratio of the morpholine to 1,3-propane sultone may be (1.0-2.0):1, for example (1.02-1.2):1;
所述反应的温度可以为15~50℃,例如20~30℃;The temperature of the reaction may be 15-50°C, such as 20-30°C;
所述反应的时间可以为1~7小时,优选为2小时;The reaction time can be 1 to 7 hours, preferably 2 hours;
根据本发明,反应完成后,还可以将得到的产物进行降温结晶、离心分离、重溶、脱色、过滤、降温结晶、离心、洗涤、干燥;According to the present invention, after the reaction is completed, the obtained product can also be subjected to cooling crystallization, centrifugal separation, redissolving, decolorization, filtration, cooling crystallization, centrifugation, washing and drying;
优选地,反应结束后,可以降温结晶数小时,通过离心分离可得粗品;Preferably, after the completion of the reaction, the temperature can be cooled and crystallized for several hours, and the crude product can be obtained by centrifugal separation;
优选地,得到粗品后,将粗品加到适量去离子水中搅拌升温至溶解,加还原剂和脱色剂,脱色数小时,降温过滤;所述还原剂优选为保险粉,所述脱色剂优选为活性炭;Preferably, after obtaining the crude product, add the crude product to an appropriate amount of deionized water, stir and heat up to dissolve, add a reducing agent and a decolorizing agent, decolorize for several hours, and filter at a lower temperature; the reducing agent is preferably hydrosulfite, and the decolorizing agent is preferably activated carbon ;
优选地,将滤液升温溶解,降温结晶,离心分离,洗涤,干燥,可得到产品,所述结晶过程可以在惰性气体的保护下进行,所述惰性气体可以为氮气或氩气,所述洗涤优选使用极性溶剂进行洗涤。Preferably, the filtrate is heated to dissolve, cooled to crystallize, centrifuged, washed, and dried to obtain the product. The crystallization process can be carried out under the protection of an inert gas, and the inert gas can be nitrogen or argon. The washing is preferably Use polar solvents for washing.
有益效果beneficial effect
1)本发明方法中所用的原料相对于使用1,3-二溴丙烷与吗啉合成吗啉基丙烷磺酸的方法中所用的原料更便宜,有利于大规模的生产应用。1) The raw material used in the method of the present invention is cheaper than the raw material used in the method for synthesizing morpholinopropanesulfonic acid using 1,3-dibromopropane and morpholine, which is beneficial to large-scale production and application.
2)本发明采用乙醇等为溶剂,溶剂易除去,满足了用户对溶剂残留的要求。2) The present invention uses ethanol and the like as a solvent, and the solvent is easy to remove, which satisfies the user's requirements for solvent residues.
3)本发明方法中的脱色采用加还原剂并氮气保护的方法,确保了MOPS的色度,使得到的产物性状更好。3) The decolorization in the method of the present invention adopts the method of adding a reducing agent and nitrogen protection, which ensures the chromaticity of the MOPS and makes the obtained product properties better.
4)本发明的制备工艺简单,操作方便,具有较高的实用性。4) The preparation process of the present invention is simple, easy to operate, and has high practicability.
具体实施方式Detailed ways
下文将结合具体实施例对本发明的生产方法做更进一步的详细说明。应当理解,下列实施例仅为示例性地说明和解释本发明,而不应被解释为对本发明保护范围的限制。凡基于本发明上述内容所实现的技术均涵盖在本发明旨在保护的范围内。The production method of the present invention will be described in further detail below with reference to specific embodiments. It should be understood that the following examples are only for illustrating and explaining the present invention, and should not be construed as limiting the protection scope of the present invention. All technologies implemented based on the above content of the present invention are covered within the intended protection scope of the present invention.
除非另有说明,以下实施例中使用的原料和试剂均为市售商品,或者可以通过已知方法制备。Unless otherwise stated, the starting materials and reagents used in the following examples are commercially available or can be prepared by known methods.
实施例1Example 1
在5000L搪玻璃反应釜中加入预处理过的无水乙醇(含水量<0.02%)2500L,搅拌下加入熔融的1,3-PS 800kg,搅拌降温到25~30℃,控温4小时,期间滴加吗啉582kg,滴加完在此温度下反应2小时,降至0℃,保温结晶10小时,离心得 2160kg湿品,母液经回收得到的酒精可用于重结晶。Add 2500L of pretreated absolute ethanol (water content < 0.02%) into a 5000L glass-lined reactor, add 800kg of molten 1,3-PS under stirring, cool down to 25-30°C with stirring, and control the temperature for 4 hours. 582kg of morpholine was added dropwise, reacted at this temperature for 2 hours, lowered to 0° C., incubated for 10 hours for crystallization, centrifuged to obtain 2160kg of wet product, and the alcohol obtained from the mother liquor could be used for recrystallization.
在3000L搪玻璃罐中加入酒精1600L,加入去离子水300kg,搅拌下加入 1080kg上步得到的湿品,升温至70℃,补加去离子水使湿品全溶,加入1kg保险粉,25kg药用活性炭,脱色1小时,压滤,滤液进入结晶罐,再加1600L酒精洗罐,通过压滤器进入结晶罐,氮气保护下,升温溶解,全溶后慢速搅拌降温至 35~40℃,物料变混浊时,保湿结晶1小时,然后降温至0~5℃,离心分离,用 20L无水乙醇洗涤2次,甩干,放入回转真空干燥器,控温80℃以下、真空度 0.08MPa以上,干燥至产品合格,得产品548kg,收率80%(以1,3-PS计),取样检测:含量99.8%(碱滴定),0.5M水溶液在260nm和280nm处的紫外吸光度均为0.02。Add 1600L of alcohol to a 3000L glass-lined jar, add 300kg of deionized water, add 1080kg of the wet product obtained in the previous step under stirring, heat up to 70°C, add deionized water to make the wet product completely dissolve, add 1kg of hydrosulfite, 25kg of medicine Use activated carbon, decolorize for 1 hour, filter by pressure, the filtrate enters the crystallizing tank, add 1600L alcohol to wash the tank, and enter the crystallizing tank through the filter press. When it becomes turbid, keep moisturizing crystals for 1 hour, then cool down to 0~5℃, centrifuge, wash twice with 20L absolute ethanol, spin dry, put into rotary vacuum dryer, control temperature below 80℃, vacuum degree above 0.08MPa , dried until the product is qualified to obtain 548kg of product, yield 80% (calculated by 1,3-PS), sampling detection: content 99.8% (alkali titration), and the UV absorbance of 0.5M aqueous solution at 260nm and 280nm are both 0.02.
实施例2Example 2
按实施例1相同的方法,加入无水乙醇2500L,加入吗啉582kg,搅拌降温至 20~25℃,4小时期间滴加1,3-PS 800kg,滴完后在此温度下反应2小时,降温至 0℃,离心分离,得湿品2180kg,分两批按实施例1的方法重结晶,最后得MOPS 554kg,收率81%,取样检测:含量99.8%(碱滴定),0.5M水溶液在260nm和280nm 处的紫外吸光度均为0.03。According to the same method of Example 1, add 2500L of absolute ethanol, add 582kg of morpholine, stir and cool down to 20~25 ℃, drip 1,3-PS 800kg during 4 hours, and react at this temperature for 2 hours after dripping, Cool to 0°C, centrifuge to obtain 2180kg of wet product, recrystallize in two batches according to the method of Example 1, finally obtain 554kg of MOPS, yield 81%, sampling detection: content 99.8% (alkali titration), 0.5M aqueous solution in The UV absorbance at 260 nm and 280 nm is both 0.03.
对照例1Comparative Example 1
按实施例1相同的方法,精制不加保险粉,结晶不用氮气保护,无水乙醇不用活性炭处理,测得产品在260nm处的紫外吸光度为0.5,在280nm处的紫外吸光度为0.2。According to the same method as Example 1, refining without adding hydrosulfite, without nitrogen protection for crystallization, without activated carbon treatment with dehydrated ethanol, the UV absorbance at 260 nm of the product was measured to be 0.5, and the UV absorbance at 280 nm was 0.2.
对照例2Comparative Example 2
按实施例1相同的方法,无水乙醇含水0.5%,其它均按实施例1进行,最后得产品450kg,收率65.7%,含量99.6%,0.1M水溶液在260nm和280nm处的紫外吸光度均为0.05。According to the same method as Example 1, the absolute ethanol contains 0.5% water, and the others are carried out according to Example 1. Finally, 450kg of product is obtained, the yield is 65.7%, and the content is 99.6%. The UV absorbance of the 0.1M aqueous solution at 260nm and 280nm is both 0.05.
对照例3Comparative Example 3
按实施例1相同的方法,吗啉投料量降到485kg,即1,3-PS与吗啉摩尔比为 1:1,最后得产品530kg,收率77.4%,含量99.7%,0.5M水溶液在260nm和280nm 处的紫外吸光度均为0.04。According to the same method as in Example 1, the morpholine feeding amount was reduced to 485kg, that is, the molar ratio of 1,3-PS and morpholine was 1:1, and the final product was 530kg, the yield was 77.4%, the content was 99.7%, and the 0.5M aqueous solution was in The UV absorbance at 260 nm and 280 nm is both 0.04.
以上,对本发明的实施方式进行了说明。但是,本发明不限定于上述实施方式。凡在本发明的精神和原则之内,所做的任何修改、等同替换、改进等,均应包含在本发明的保护范围之内。The embodiments of the present invention have been described above. However, the present invention is not limited to the above-described embodiments. Any modification, equivalent replacement, improvement, etc. made within the spirit and principle of the present invention shall be included within the protection scope of the present invention.
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201711206086.3A CN109836397A (en) | 2017-11-27 | 2017-11-27 | A kind of preparation method of biological buffer-morpholinopropane sulfonic acid (MOPS) |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201711206086.3A CN109836397A (en) | 2017-11-27 | 2017-11-27 | A kind of preparation method of biological buffer-morpholinopropane sulfonic acid (MOPS) |
Publications (1)
Publication Number | Publication Date |
---|---|
CN109836397A true CN109836397A (en) | 2019-06-04 |
Family
ID=66878996
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201711206086.3A Pending CN109836397A (en) | 2017-11-27 | 2017-11-27 | A kind of preparation method of biological buffer-morpholinopropane sulfonic acid (MOPS) |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN109836397A (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110790726A (en) * | 2019-11-13 | 2020-02-14 | 湖南韵邦生物医药有限公司 | Production method of 3-morpholine propanesulfonic acid |
CN110981831A (en) * | 2019-12-05 | 2020-04-10 | 湖北吉和昌化工科技有限公司 | Preparation method of 3-morpholine propanesulfonic acid |
CN113135846A (en) * | 2021-04-07 | 2021-07-20 | 吉和昌新材料(荆门)有限公司 | Preparation method of sulfobetaine type waterborne polyurethane chain extender |
CN116283830A (en) * | 2023-01-08 | 2023-06-23 | 湖南吴赣药业有限公司 | Preparation method of high-purity 3-morpholinopropane sulfonic acid |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001085678A1 (en) * | 2000-05-10 | 2001-11-15 | Raschig Gmbh | Method for the production of $g(v)-aminoalkylsulphonic acids |
-
2017
- 2017-11-27 CN CN201711206086.3A patent/CN109836397A/en active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001085678A1 (en) * | 2000-05-10 | 2001-11-15 | Raschig Gmbh | Method for the production of $g(v)-aminoalkylsulphonic acids |
Non-Patent Citations (2)
Title |
---|
CAIBO YUE: "Aromatic Compounds Mannich Reaction Using Economical Acidic Ionic Liquids Based on Morpholinium Salts as Dual Solvent-Catalysts", 《SYNTHETIC COMMUNICATIONS》 * |
卞克建等: "磺酸型生物缓冲剂的合成", 《化学试剂》 * |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110790726A (en) * | 2019-11-13 | 2020-02-14 | 湖南韵邦生物医药有限公司 | Production method of 3-morpholine propanesulfonic acid |
CN110981831A (en) * | 2019-12-05 | 2020-04-10 | 湖北吉和昌化工科技有限公司 | Preparation method of 3-morpholine propanesulfonic acid |
CN110981831B (en) * | 2019-12-05 | 2022-02-08 | 湖北吉和昌化工科技有限公司 | Preparation method of 3-morpholine propanesulfonic acid |
CN113135846A (en) * | 2021-04-07 | 2021-07-20 | 吉和昌新材料(荆门)有限公司 | Preparation method of sulfobetaine type waterborne polyurethane chain extender |
CN116283830A (en) * | 2023-01-08 | 2023-06-23 | 湖南吴赣药业有限公司 | Preparation method of high-purity 3-morpholinopropane sulfonic acid |
CN116283830B (en) * | 2023-01-08 | 2025-02-18 | 湖南吴赣药业有限公司 | A kind of preparation method of high-purity 3-morpholinepropanesulfonic acid |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN109836397A (en) | A kind of preparation method of biological buffer-morpholinopropane sulfonic acid (MOPS) | |
CN110615788B (en) | Preparation process of high-purity apixaban | |
CN104788345A (en) | High-purity metformin hydrochloride preparation method | |
CN106892950B (en) | Preparation method of high-content troxerutin | |
CN105669679A (en) | Preparation method of PCI-32765 crystal form A | |
CN110655511A (en) | Preparation and refining method of high-purity empagliflozin | |
CN103275150A (en) | Method for refining and preparing erythromycin thiocyanate | |
WO2021212535A1 (en) | Method for refining benzhexol hydrochloride | |
CN111592539A (en) | Preparation method of trifluoro-benzene pyrimidine | |
CN108314696B (en) | Utilization method of 2-hydroxy-1, 3, 5-tri-O-benzoyl-alpha-D-ribofuranose crystallization mother liquor | |
CN113121621A (en) | Method for preparing sucralose-6-acetate by enzymatic synthesis of sucrose-6-acetate | |
CN114437146B (en) | Production process of sucralose-6-acetate | |
CN107151261B (en) | A kind of crystal form of dirithromycin compound and its crystal preparation method | |
CN114269728A (en) | Continuous Process for the Preparation of Crystalline Soxagliflozin Form II | |
CN113173959B (en) | A kind of method for removing impurities in enzymatic synthesis of sucrose-6-acetate system | |
CN112500414B (en) | Preparation method of O-monoacetylganciclovir | |
CN105237419B (en) | The method for synthesizing L norvalines | |
CN102432484B (en) | A kind of crystallization method of preparing L-phenylalanine monohydrate | |
CN113185474B (en) | Preparation method of florfenicol intermediate | |
CN112457242B (en) | Preparation method of lacidipine impurity B | |
CN119751398A (en) | A crystal form of acetylated dapagliflozin and preparation method thereof | |
CN109836398A (en) | A kind of preparation method of two ethanesulfonic acid 1.5Na salt of special biological buffer-piperazine | |
CN114671793A (en) | Preparation method of 4- (5, 5-dihydroxymethyl-2-oxypyrrolidinyl) -3-guanidinomethylenebenzoic acid | |
CN116425811A (en) | Sucralose solution crystallization process | |
CN118420591A (en) | Topiroxostat purification method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20190604 |